Does NIVOLUMAB Cause Pleural effusion? 1,061 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,061 reports of Pleural effusion have been filed in association with NIVOLUMAB (OPDIVO). This represents 1.2% of all adverse event reports for NIVOLUMAB.
1,061
Reports of Pleural effusion with NIVOLUMAB
1.2%
of all NIVOLUMAB reports
329
Deaths
782
Hospitalizations
How Dangerous Is Pleural effusion From NIVOLUMAB?
Of the 1,061 reports, 329 (31.0%) resulted in death, 782 (73.7%) required hospitalization, and 145 (13.7%) were considered life-threatening.
Is Pleural effusion Listed in the Official Label?
Yes, Pleural effusion is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
DOXORUBICIN (849)
Which NIVOLUMAB Alternatives Have Lower Pleural effusion Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE